| Jeremy John Stringer, DNP CRNA | |
|
621 3rd St S, Glasgow, MT 59230 | |
| (406) 228-3500 | |
| Not Available |
| Full Name | Jeremy John Stringer |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 6 Years |
| Location | 621 3rd St S, Glasgow, Montana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366719460 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 130895 (Montana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Frances Mahon Deaconess Hospital | Glasgow, MT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Frances Mahon Deaconess Hospital | 3173430949 | 35 |
News Archive
Zosano Pharma, Inc., a privately held pharmaceutical company developing products using a novel transdermal delivery technology, announced publication in the current issue of the Journal of Clinical Endocrinology and Metabolism of results from a positive phase 2 study of its rapid-delivery transdermal patch (ZP-PTH) for the treatment of postmenopausal osteoporosis.
In a reaction to the European Food Safety Authority's (EFSA) announcement at the end of June, the European Salt Producers' Association, in brief EuSalt, maintains its position that the current scientific understanding does not justify the reduction of the daily salt intake for healthy people.
The Center for Business Intelligence (CBI), a division of Advanstar Communications, is pleased to announce a partnership with the Children's Rare Disease Network and The Global Genes Project for the 6th Annual Rare Disease Leadership Summit coming up July 12 - 13, 2011 at the Doubletree Hotel in Washington, D.C.
An eight-week mindfulness-based program was effective for reducing stress and depressive symptoms while increasing general well-being in a study of infertile women.
› Verified 2 days ago
| Entity Name | Frances Mahon Deaconess Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639117013 PECOS PAC ID: 3173430949 Enrollment ID: O20031111000918 |
News Archive
Zosano Pharma, Inc., a privately held pharmaceutical company developing products using a novel transdermal delivery technology, announced publication in the current issue of the Journal of Clinical Endocrinology and Metabolism of results from a positive phase 2 study of its rapid-delivery transdermal patch (ZP-PTH) for the treatment of postmenopausal osteoporosis.
In a reaction to the European Food Safety Authority's (EFSA) announcement at the end of June, the European Salt Producers' Association, in brief EuSalt, maintains its position that the current scientific understanding does not justify the reduction of the daily salt intake for healthy people.
The Center for Business Intelligence (CBI), a division of Advanstar Communications, is pleased to announce a partnership with the Children's Rare Disease Network and The Global Genes Project for the 6th Annual Rare Disease Leadership Summit coming up July 12 - 13, 2011 at the Doubletree Hotel in Washington, D.C.
An eight-week mindfulness-based program was effective for reducing stress and depressive symptoms while increasing general well-being in a study of infertile women.
› Verified 2 days ago
| Entity Name | U S Anesthesia Partners Of Montana P C |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588359855 PECOS PAC ID: 8022474675 Enrollment ID: O20230524000324 |
News Archive
Zosano Pharma, Inc., a privately held pharmaceutical company developing products using a novel transdermal delivery technology, announced publication in the current issue of the Journal of Clinical Endocrinology and Metabolism of results from a positive phase 2 study of its rapid-delivery transdermal patch (ZP-PTH) for the treatment of postmenopausal osteoporosis.
In a reaction to the European Food Safety Authority's (EFSA) announcement at the end of June, the European Salt Producers' Association, in brief EuSalt, maintains its position that the current scientific understanding does not justify the reduction of the daily salt intake for healthy people.
The Center for Business Intelligence (CBI), a division of Advanstar Communications, is pleased to announce a partnership with the Children's Rare Disease Network and The Global Genes Project for the 6th Annual Rare Disease Leadership Summit coming up July 12 - 13, 2011 at the Doubletree Hotel in Washington, D.C.
An eight-week mindfulness-based program was effective for reducing stress and depressive symptoms while increasing general well-being in a study of infertile women.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jeremy John Stringer, DNP CRNA 621 3rd St S, Glasgow, MT 59230-2604 Ph: (406) 228-3500 | Jeremy John Stringer, DNP CRNA 621 3rd St S, Glasgow, MT 59230 Ph: (406) 228-3500 |
News Archive
Zosano Pharma, Inc., a privately held pharmaceutical company developing products using a novel transdermal delivery technology, announced publication in the current issue of the Journal of Clinical Endocrinology and Metabolism of results from a positive phase 2 study of its rapid-delivery transdermal patch (ZP-PTH) for the treatment of postmenopausal osteoporosis.
In a reaction to the European Food Safety Authority's (EFSA) announcement at the end of June, the European Salt Producers' Association, in brief EuSalt, maintains its position that the current scientific understanding does not justify the reduction of the daily salt intake for healthy people.
The Center for Business Intelligence (CBI), a division of Advanstar Communications, is pleased to announce a partnership with the Children's Rare Disease Network and The Global Genes Project for the 6th Annual Rare Disease Leadership Summit coming up July 12 - 13, 2011 at the Doubletree Hotel in Washington, D.C.
An eight-week mindfulness-based program was effective for reducing stress and depressive symptoms while increasing general well-being in a study of infertile women.
› Verified 2 days ago
Amy Renee Wood I, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 621 3rd St S, Glasgow, MT 59230 Phone: 406-228-3500 Fax: 406-228-3680 | |
Thomas Eugene Schultz, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 621 3rd St S, Glasgow, MT 59230 Phone: 406-228-3500 | |
Lisa Elaine Ball, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 621 3rd St S, Glasgow, MT 59230 Phone: 406-228-3500 | |
Mr. Gerry Eugene Fink, CRNA, MS Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 621 3rd St S, Glasgow, MT 59230 Phone: 406-228-3500 Fax: 406-228-3520 |